Trans-1,4-Dibromo-2-butene CAS 821-06-7 Purity ≥99.0% (GC) Hoobkas Zoo
Chaw tsim tshuaj paus nrog High Quality thiab Competitive Nqe
Kev muag khoom lag luam Aliskiren Related Intermediates:
CAS: 173334-57-1 Nr
Aliskiren Hemifumarate CAS NO: 173334-58-2
(S)-4-Benzyl-2-Oxazolidinone CAS: 90719-32-7
(R)-4-Benzyl-2-Oxazolidinone CAS TSIS TAU: 102029-44-7
Tom ntej: Trans-1,4-Dibromo-2-Butene CAS: 821-06-7
Isovaleryl Chloride CAS 108-12-3
D-Phenylalanine CAS: 673-06-3
D-Phenylalaninol CAS: 5267-64-1
| Tshuaj npe | trans-1,4-Dibromo-2-Butene |
| Synonyms | (E)-1,4-Dibromobut-2-ene;(2E)-1,4-Dibromo-2-butene |
| CAS Nr | 821-06-7 : kuv |
| CAT Number | Qauv: RF-PI149 |
| Tshuag xwm txheej | Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons |
| Molecular Formula | C4H6Br2 |
| Molecular Luj | 213.9 ib |
| Solubility hauv Methanol | Yuav luag Transparency |
| Hom | Ruifu Tshuaj |
| Yam khoom | Specifications |
| Qhov tshwm sim | Dawb rau Brown Khoom |
| Purity / Analysis Method | ≥99.0% (GC) |
| Cis-Cov ntsiab lus | ≤ 0.20% |
| Melting Point | 50.0 ℃ ~ 54.0 ℃ |
| Tetrabromobutane (TBB) | ≤0.50% |
| Moisture (KF) | ≤ 0.20% |
| Test Standard | Enterprise Standard |
| Kev siv | Aliskiren (CAS 173334-57-1), Aliskiren Hemifumarate (CAS 173334-58-2) |
Pob: Lub raj mis, Aluminium ntawv ci hnab, Cardboard nruas, 25kg / Nruas, los yog raws li tus neeg yuav tsum tau muaj.
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb, noo noo thiab kab tsuag.
Shanghai Ruifu Chemical Co., Ltd. yog cov chaw tsim khoom thiab cov chaw muag khoom ntawm trans-1,4-Dibromo-2-Butene (CAS: 821-06-7) nrog cov khoom zoo, dav siv hauv organic synthesis, synthesis ntawm cov tshuaj intermediates thiab active tshuaj ingredient (API) synthesis.
trans-1,4-Dibromo-2-Butene (CAS: 821-06-7) yog ib qho tseem ceeb nruab nrab ntawm cov synthesis ntawm Aliskiren (CAS: 173334-57-1), API.Aliskiren yog thawj-hauv-chav tshuaj antihypertensive uas ua los ntawm kev cuam tshuam ncaj qha ntawm renin.Nws tau qhia rau kev tswj hwm qhov ncauj xws li monotherapy lossis ua ke nrog lwm cov tshuaj tiv thaiv kab mob.Qhov inhibition ntawm renin los ntawm aliskiren ua rau txo qis ntawm angiotensin I, angiotensin II, thiab aldosterone, tag nrho cov uas ua rau cov nyhuv antihypertensive.
